BERGMANN ANTHONY (Chief Financial Officer) sold 7.4% of their position (900.00 shares) of CAPRICOR THERAPEUTICS, INC. on the open market
Open‑market sale worth $27.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+500.00
Price / share
$3.18
Trade value
$1.59K
% of position
Common Stock
Shares
−500.00
Price / share
$30.00
Trade value
$15K
% of position
Common Stock
Shares
+400.00
Price / share
$3.18
Trade value
$1.27K
% of position
Common Stock
Shares
−400.00
Price / share
$30.00
Trade value
$12K
% of position
Net shares
+0.00
Net value
-$24.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/22/2026 | M · Option Exercise | +500.00 | $3.18 | $1.59K | 4.5% | 11.22K | 11.72K |
| Common Stock Direct | 6/22/2026 | S · Sale | −500.00 | $30.00 | $15K | 4.3% | 11.72K | 11.22K |
| Common Stock Direct | 6/24/2026 | M · Option Exercise | +400.00 | $3.18 | $1.27K | 3.6% | 11.22K | 11.62K |
| Common Stock Direct | 6/24/2026 | S · Sale | −400.00 | $30.00 | $12K | 3.4% | 11.62K | 11.22K |
| Total | +0.00 | -$24.14K | ||||||
Stock Option (Right to Buy)
Common Stock
500.00 shares
Shares
−500.00
Strike price
3.18
Held after
116.48K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
400.00 shares
Shares
−400.00
Strike price
3.18
Held after
116.08K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock500.00 shares | 6/22/2026 | M · Option Exercise | −500.00 | 3.18 | — | 116.48K |
| Stock Option (Right to Buy) Direct | Common Stock400.00 shares | 6/24/2026 | M · Option Exercise | −400.00 | 3.18 | — | 116.08K |